Predicting Outcomes in Posttransplant Diabetes Mellitus Via microRNA
Recruiting
Observational Study
Diabetes Mellitus
Kidney Transplant
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 130 (estimated)
- Sponsor
- University Hospital, Martin · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The study aims to improve the prediction and early detection of post-transplant diabetes mellitus (PTDM) in kidney transplant recipients. The investigators are investigating whether specific microRNA profiles measured 3 months after transplantation can reliably predict the development of PTDM within the following one to two years.
Additionally, the investigators are evaluating how traditional ris…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Adult patients undergoing kidney transplantation.
* Absence of pre-existing type 1 or type 2 diabetes mellitus.
* Willingness to provide informed consent and comply with study procedures.
Exclusion Criteria:
* Pre-existing type 1 or type 2 diabetes mellitus.
* Previous organ…
Contacts